Mediphase Venture Partners
Venture capitalLate Stage · 2 people tracked
Find your way into Mediphase Venture Partners
Sign up to find every way you can get introduced to Mediphase Venture Partners
- Your email: who you already know at Mediphase Venture Partners, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Mediphase Venture Partners team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Fund manager profile
Mediphase Venture Partners is a venture fund manager. SEC filings show 1 venture fund on record, most recently MEDIPHASE VENTURE PARTNERS ANNEX FUND LP ($500K offering) filed February 2012.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 2 people
from public directoriesWhat they invest in
from 1 of 1 portfolio companiesBiotech ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathTetraphase Pharmaceuticals was a Watertown, MA biopharmaceutical company developing novel tetracycline antibiotics, including its lead drug Xerava (eravacycline) for multidrug-resistant bacterial infections.
BiotechWatertown, US
Guy Macdonald(Director)inLarry Edwards(Executive Officer, Director)inMaria Stahl(Executive Officer)inChristopher Watt(Executive Officer)
BoardL. Patrick Gage(Director)Keith Maher(Director)
Co-investorsBay City CapitalF-Prime CapitalExcel Venture ManagementFlagship Ventures
Exits · 1
1 acquisitionsTetraphase Pharmaceuticalsacq. by La Jolla Pharmaceutical Company
Frequently asked questions
- What stage does Mediphase Venture Partners invest at?
- Mediphase Venture Partners invests at the Late Stage stage.
Similar investors
3TS Capital Partners is a European technology-focused growth investment adviser whose advised funds provide growth capital, typically leading or co-leading substantial funding rounds for innovative tech companies primarily in the DACH, CEE and Nordic regions.
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.



